Acadia Realty Trust (AKR) 36.79 $AKR Regency Centers

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Acadia Realty Trust (AKR) 36.79 $AKR

Regency Centers Prices Over 4.3M Common Shares Offering
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:32AM CDT
Regency Centers Corporation (REG) announced the pricing of an underwritten public offering of 4,350,000 common shares.
SPG: 222.47 (+1.01), REG: 82.16 (+0.48), AKR: 36.79 (+0.17), MAC: 89.07 (+0.52)

Simon Property to Bring Top Tenants to Brickell City Centre
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:20AM CDT
Simon Property Group Inc. (SPG), along with Swire Properties Inc and Whitman Family Development, LLC announced the joining of five top retail players to the Brickell City Centre's 500,000 square-foot shopping center.
SPG: 222.47 (+1.01), REG: 82.16 (+0.48), AKR: 36.79 (+0.17), MAC: 89.07 (+0.52)

Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)
Marketwired - Mon Jun 27, 6:00AM CDT
THOROFARE, NJ--(Marketwired - Jun 27, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR) (the "Company" or "Akers Bio", a developer of rapid health information technologies, has signed its first distribution agreement for BreathScan OxiChek™ ("OxiChek" with Aero-Med, a division of Cardinal Health, a Fortune 500 health care services organization.
AKER: 2.84 (+0.06), AKR: 36.79 (+0.17)

Acadia Realty Trust to Present at NAREIT's REITWeek Investor Forum and Provides Core Portfolio Transaction Update
BusinessWire - Fri Jun 03, 7:30AM CDT
Acadia Realty Trust (NYSE:AKR) ("Acadia" or the "Company" today provided an update on its core portfolio ("Core" acquisition activity, and announced that year-to-date, the Company has closed on $121.5 million of Core acquisitions and is under contract to acquire another $290.6 million, for a total of $412.1 million of Core acquisitions. These high-quality street and urban retail properties are located within key retail corridors in gateway cities, serving consumers' and retailers' continued desire for live-work-play retail experiences.
AKR: 36.79 (+0.17)

Acadia Realty Trust to Present at NAREIT's REITWeek Investor Forum
BusinessWire - Wed Jun 01, 12:31PM CDT
Acadia Realty Trust (NYSE:AKR) ("Acadia" or the "Company" today announced that it will participate in REITWeek 2016: NAREIT's Investor Forum(R), which will be held on June 7-9, 2016 in New York, New York. Kenneth F. Bernstein, Acadia's President and Chief Executive Officer, is scheduled to make a company presentation on Wednesday, June 8, 2016 at 2:45 p.m. ET.
AKR: 36.79 (+0.17)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 2.84 (+0.06), AKR: 36.79 (+0.17)

Acadia Realty Trust Announces $0.25 Per Share Quarterly Dividend
BusinessWire - Mon May 09, 3:15PM CDT
Acadia Realty Trust (NYSE:AKR) today announced that its Board of Trustees has declared a cash dividend of $0.25 per Common Share for the quarter ended June 30, 2016, payable on July 15, 2016 to holders of record as of June 30, 2016.
AKR: 36.79 (+0.17)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company", a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 2.84 (+0.06), AKR: 36.79 (+0.17)

Acadia Realty Trust reports 1Q results
Automated Insights - Tue Apr 26, 4:43PM CDT
RYE, N.Y. (AP) _ Acadia Realty Trust (AKR) on Tuesday reported a key measure of profitability in its first quarter.
AKR: 36.79 (+0.17)

Acadia Realty Trust Reports First Quarter 2016 Operating Results
BusinessWire - Tue Apr 26, 3:15PM CDT
Acadia Realty Trust (NYSE:AKR) ("Acadia" or the "Company" today reported operating results for the quarter ended March 31, 2016. All per share amounts, below, are on a fully-diluted basis.
AKR: 36.79 (+0.17)

Why Earnings Season Could Be Great for Acadia Realty (AKR)
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 7:32AM CDT
Acadia Realty (AKR) looks like an exciting pick for investors as it is poised to beat at earnings season.
AKR: 36.79 (+0.17)

Acadia Realty Trust Names John Gottfried as Its Next CFO
BusinessWire - Mon Apr 18, 7:30AM CDT
Acadia Realty Trust (NYSE:AKR) ("Acadia" or the "Company" today announced that John Gottfried will succeed Jon Grisham as Chief Financial Officer on June 27, 2016. Mr. Grisham, who had previously announced his intention to retire, will serve as the Company's Chief Financial Officer through June 26, 2016 and is expected to remain with the Company through a transition period.
AKR: 36.79 (+0.17)

Acadia Realty Trust Set to Possibly Rebound After Yesterday's Selloff of 3.24%
Comtex SmarTrend(R) - Tue Apr 05, 4:17PM CDT
Acadia Realty Trust (NYSE:AKR) traded in a range yesterday that spanned from a low of $33.92 to a high of $34.70. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $34.76 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKR: 36.79 (+0.17)

Acadia Realty Trust Announces Pricing of Common Share Offering on a Forward Basis
BusinessWire - Tue Apr 05, 6:00AM CDT
Acadia Realty Trust (NYSE:AKR - "Acadia" or the "Company" today announced the pricing of a public offering of 3,600,000 of the Company's common shares of beneficial interest (the "Common Shares" on a forward basis in connection with the forward sale agreement described below, which will result in approximately $124.9 million of gross proceeds (assuming such forward sale agreement is physically settled in full based on the offer price to the public per share of $34.70) before any underwriting compensation and offering expenses. The offering is expected to close on or about April 8, 2016, subject to customary closing conditions. The underwriters have been granted a 30-day option to purchase up to an additional 540,000 Common Shares (the "Option to Purchase Additional Shares" upon the same terms. Barclays and Citigroup are acting as the underwriters of the offering.
AKR: 36.79 (+0.17)

Acadia Realty Trust Announces Offering of Common Shares
BusinessWire - Mon Apr 04, 3:03PM CDT
Acadia Realty Trust (NYSE:AKR - "Acadia" or the "Company" announced today the commencement of a public offering of up to approximately 3,600,000 of the Company's common shares of beneficial interest (the "Common Shares" on a forward basis in connection with the forward sale agreement described below. The underwriters have been granted a 30-day option to purchase up to an additional 540,000 Common Shares (the "Option to Purchase Additional Shares". Barclays and Citigroup are acting as the underwriters of the offering.
AKR: 36.79 (+0.17)

Acadia Realty Trust to Announce First Quarter 2016 Earnings on April 26, 2016
BusinessWire - Thu Mar 31, 10:44AM CDT
Acadia Realty Trust (NYSE:AKR) will release its first quarter 2016 earnings on Tuesday, April 26, 2016 after market close. Management will conduct a conference call on Wednesday, April 27, 2016 at 12:00 PM ET to review the Company's earnings and operating results. Dial-in and webcast information is listed below.
AKR: 36.79 (+0.17)

Acadia Realty Trust Announces 2016 Annual Meeting Date
BusinessWire - Wed Mar 30, 2:09PM CDT
Acadia Realty Trust (NYSE:AKR) today announced the date of the Company's 2016 Annual Shareholder Meeting.
AKR: 36.79 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
icles